Results 201 to 210 of about 42,994 (239)
Fluorodeoxyglucose F18 positron emission tomography in a case of slowly progressive pure alexia
Neurocase, 2013 We describe a 71-year-old patient with slowly progressive pure alexia in which analysis of her fluorodeoxyglucose FDG-PET scan revealed an area of focal hypometabolism in the visual word form area. She presented with difficulty reading. Examination revealed pure alexia with preservation of other cognitive domains. Brain MRI revealed only slight atrophy.
Jonathan Graff‐Radford +3 more
semanticscholar +4 more sources
Clinical Imaging, 2020 The uptake of 18F-FDG is higher in most malignancies than in benign tumors. This study aimed to investigate the diagnostic value of 18F-FDG PET/CT in vertebral vascular tumors.We retrospectively collected PET/CT and clinical data of patients with vertebral vascular tumors and analyzed the location, number, and bone destruction and FDG uptake features ...
Le Song +3 more
semanticscholar +4 more sources
Interaction of Colony-Stimulating Factors and Fluorodeoxyglucose F18 Positron Emission Tomography
Annals of Pharmacotherapy, 2002 OBJECTIVE: To evaluate reports of altered diagnostic images with fluorodeoxyglucose F18 (FDG) positron emission tomography (PET) after treatment with colony-stimulating factors (CSFs). DATA SOURCES: Literature was identified by a MEDLINE search (1966–December 2001). Key search terms included granulocyte colony-stimulating factor, granulocyte—macrophage
Dmitri Mayer, Edward M. Bednarczyk
semanticscholar +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Positron emission tomography with fluorodeoxyglucose-F18 in an animal model of mania
Psychiatry Research: Neuroimaging, 2008Intracerebroventricular (ICV) administration of ouabain to young adult rats has been suggested to model human bipolar mania. In the human condition, mania and bipolar depression are both associated with reductions in frontal cerebral metabolism. We utilized [(18)F]-fluorodeoxyglucose [(18)FDG] positron emission tomography (PET) to visualize glucose ...
Matthew Tyler, Hougland +5 more
openaire +3 more sources
Psychiatry Research: Neuroimaging, 2008
At present, there is still no consensus on the choice of the reference area in positron emission tomography (PET) studies of Alzheimer's disease (AD). In this study, PET scans with fluorodeoxyglucose-F18 were carried out in the following groups of subjects: 47 patients with probable AD, 8 patients with mild cognitive impairment, and 15 age-similar ...
Yakushev, Igor +9 more
openaire +4 more sources
At present, there is still no consensus on the choice of the reference area in positron emission tomography (PET) studies of Alzheimer's disease (AD). In this study, PET scans with fluorodeoxyglucose-F18 were carried out in the following groups of subjects: 47 patients with probable AD, 8 patients with mild cognitive impairment, and 15 age-similar ...
Yakushev, Igor +9 more
openaire +4 more sources
Lung Neoplasms with Low F18-Fluorodeoxyglucose Avidity
PET Clinics, 2018Some malignant lung neoplasms may demonstrate low or absent uptake on F18-fluorodeoxyglucose (FDG) PET/computed tomography. Pathologic type and clinical stage are independent factors associated with FDG avidity. Among lung malignancies with low FDG avidity, adenocarcinoma in situ and carcinoid are the most common.
Yiyan Liu
openaire +3 more sources
Non–Small-Cell Lung Cancer PET Imaging Beyond F18 Fluorodeoxyglucose
PET Clinics, 2018F18 Flurodeoxyglucose (FDG) is a nonspecific PET tracer representing tumor energy metabolism, with common false-positive and false-negative findings in clinical practice. Non-small cell lung cancer is highly heterogeneous histologically, biologically, and molecularly.
G. Cheng
openaire +3 more sources
European Journal of Radiology, 2018
This systematic review and meta-analysis was performed to assess the staging/restaging performance of F18-fluorodeoxyglucose (FDG) positron emission tomography (PET)/magnetic resonance imaging (MRI) in breast cancer.A comprehensive search was performed in PubMed databases for studies reporting the staging performance of F18-FDG PET/MRI in breast cancer
Chun-Yi, Lin +2 more
openaire +3 more sources
This systematic review and meta-analysis was performed to assess the staging/restaging performance of F18-fluorodeoxyglucose (FDG) positron emission tomography (PET)/magnetic resonance imaging (MRI) in breast cancer.A comprehensive search was performed in PubMed databases for studies reporting the staging performance of F18-FDG PET/MRI in breast cancer
Chun-Yi, Lin +2 more
openaire +3 more sources